APO Research
Talk to an analyst

APO RESEARCH · REPORT

Enzymes for β-lactam Antibiotics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Enzymes for β-lactam Antibiotics Market Outlook and Growth Opportunities 2026

27 December 2025190 pages

Choose your research edition.

Industry ResearchEnzymes for β-lactam Antibiotics Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Enzymes for β-lactam Antibiotics Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Enzymes for β-lactam Antibiotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Enzymes for β-lactam Antibiotics Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Enzymes for β-lactam Antibiotics Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Enzymes for β-lactam Antibiotics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Enzymes for β-lactam Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Enzymes for β-lactam Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Enzymes for β-lactam Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Enzymes for β-lactam Antibiotics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Enzymes for β-lactam Antibiotics market include MCE, Amicogen, Biosynth, Crawford Wisdom International, Creative Enzymes, Fermenta Biotech Ltd., Merck & Co., MuseChem Chemicals and Biolab, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Enzymes for β-lactam Antibiotics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Enzymes for β-lactam Antibiotics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Enzymes for β-lactam Antibiotics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Enzymes for β-lactam Antibiotics market size, projected growth trends, production technologies, key applications, and end-use industries.

Enzymes for β-lactam Antibiotics Segment by Company

MCE

Amicogen

Biosynth

Crawford Wisdom International

Creative Enzymes

Fermenta Biotech Ltd.

Merck & Co.

MuseChem Chemicals

Biolab

Hangzhou Chuangke Biotech

Hangzhou Junfeng Bioengineering

Hunan Fulaige Biotech

Shanghai Kekai Biotech

Enzymes for β-lactam Antibiotics Segment by Type

Penicillin Acylase

β-lactamase

Other

Enzymes for β-lactam Antibiotics Segment by Application

Cephalosporins

Penicillin and Its Derivatives

Monoamide Ring

Other

Enzymes for β-lactam Antibiotics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Enzymes for β-lactam Antibiotics status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Enzymes for β-lactam Antibiotics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Enzymes for β-lactam Antibiotics significant trends, drivers, influence factors in global and regions.

6. To analyze Enzymes for β-lactam Antibiotics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enzymes for β-lactam Antibiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enzymes for β-lactam Antibiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enzymes for β-lactam Antibiotics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Enzymes for β-lactam Antibiotics market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Enzymes for β-lactam Antibiotics industry.

Chapter 3: Detailed analysis of Enzymes for β-lactam Antibiotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Enzymes for β-lactam Antibiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Enzymes for β-lactam Antibiotics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Enzymes for β-lactam Antibiotics Industry Trends Table 2. Enzymes for β-lactam Antibiotics Industry Drivers Table 3. Enzymes for β-lactam Antibiotics Industry Opportunities and Challenges Table 4. Enzymes for β-lactam Antibiotics Industry Restraints Table 5. Global Enzymes for β-lactam Antibiotics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Enzymes for β-lactam Antibiotics Revenue Share by Company (2021-2026) Table 7. Global Enzymes for β-lactam Antibiotics Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Enzymes for β-lactam Antibiotics Sales Volume Share by Company (2021-2026) Table 9. Global Enzymes for β-lactam Antibiotics Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Enzymes for β-lactam Antibiotics Company Ranking, (2024-2026) & (USD Million) Table 11. Global Enzymes for β-lactam Antibiotics Key Company Manufacturing Base & Headquarters Table 12. Global Enzymes for β-lactam Antibiotics Company, Product Type & Application Table 13. Global Enzymes for β-lactam Antibiotics Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Enzymes for β-lactam Antibiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Penicillin Acylase Table 18. Significant Companies of β-lactamase Table 19. Significant Companies of Other Table 20. Global Enzymes for β-lactam Antibiotics Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Enzymes for β-lactam Antibiotics Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Enzymes for β-lactam Antibiotics Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Enzymes for β-lactam Antibiotics Sales Volume Share by Type (2021-2026) Table 24. Global Enzymes for β-lactam Antibiotics Sales Volume Share by Type (2027-2032) Table 25. Global Enzymes for β-lactam Antibiotics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Enzymes for β-lactam Antibiotics Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Enzymes for β-lactam Antibiotics Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Enzymes for β-lactam Antibiotics Sales Value Share by Type (2021-2026) Table 29. Global Enzymes for β-lactam Antibiotics Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Cephalosporins Table 31. Significant Companies of Penicillin and Its Derivatives Table 32. Significant Companies of Monoamide Ring Table 33. Significant Companies of Other Table 34. Global Enzymes for β-lactam Antibiotics Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Enzymes for β-lactam Antibiotics Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Enzymes for β-lactam Antibiotics Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Enzymes for β-lactam Antibiotics Sales Volume Share by Application (2021-2026) Table 38. Global Enzymes for β-lactam Antibiotics Sales Volume Share by Application (2027-2032) Table 39. Global Enzymes for β-lactam Antibiotics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Enzymes for β-lactam Antibiotics Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Enzymes for β-lactam Antibiotics Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Enzymes for β-lactam Antibiotics Sales Value Share by Application (2021-2026) Table 43. Global Enzymes for β-lactam Antibiotics Sales Value Share by Application (2027-2032) Table 44. Global Enzymes for β-lactam Antibiotics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Enzymes for β-lactam Antibiotics Sales by Region (2021-2026) & (K Units) Table 46. Global Enzymes for β-lactam Antibiotics Sales Market Share by Region (2021-2026) Table 47. Global Enzymes for β-lactam Antibiotics Sales by Region (2027-2032) & (K Units) Table 48. Global Enzymes for β-lactam Antibiotics Sales Market Share by Region (2027-2032) Table 49. Global Enzymes for β-lactam Antibiotics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Enzymes for β-lactam Antibiotics Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Enzymes for β-lactam Antibiotics Sales Value Share by Region (2021-2026) Table 52. Global Enzymes for β-lactam Antibiotics Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Enzymes for β-lactam Antibiotics Sales Value Share by Region (2027-2032) Table 54. Global Enzymes for β-lactam Antibiotics Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Enzymes for β-lactam Antibiotics Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Enzymes for β-lactam Antibiotics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Enzymes for β-lactam Antibiotics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Enzymes for β-lactam Antibiotics Sales by Country (2021-2026) & (K Units) Table 59. Global Enzymes for β-lactam Antibiotics Sales Market Share by Country (2021-2026) Table 60. Global Enzymes for β-lactam Antibiotics Sales by Country (2027-2032) & (K Units) Table 61. Global Enzymes for β-lactam Antibiotics Sales Market Share by Country (2027-2032) Table 62. Global Enzymes for β-lactam Antibiotics Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Enzymes for β-lactam Antibiotics Sales Value Market Share by Country (2021-2026) Table 64. Global Enzymes for β-lactam Antibiotics Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Enzymes for β-lactam Antibiotics Sales Value Market Share by Country (2027-2032) Table 66. MCE Company Information Table 67. MCE Business Overview Table 68. MCE Enzymes for β-lactam Antibiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. MCE Enzymes for β-lactam Antibiotics Product Portfolio Table 70. MCE Recent Development Table 71. Amicogen Company Information Table 72. Amicogen Business Overview Table 73. Amicogen Enzymes for β-lactam Antibiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Amicogen Enzymes for β-lactam Antibiotics Product Portfolio Table 75. Amicogen Recent Development Table 76. Biosynth Company Information Table 77. Biosynth Business Overview Table 78. Biosynth Enzymes for β-lactam Antibiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Biosynth Enzymes for β-lactam Antibiotics Product Portfolio Table 80. Biosynth Recent Development Table 81. Crawford Wisdom International Company Information Table 82. Crawford Wisdom International Business Overview Table 83. Crawford Wisdom International Enzymes for β-lactam Antibiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Crawford Wisdom International Enzymes for β-lactam Antibiotics Product Portfolio Table 85. Crawford Wisdom International Recent Development Table 86. Creative Enzymes Company Information Table 87. Creative Enzymes Business Overview Table 88. Creative Enzymes Enzymes for β-lactam Antibiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Creative Enzymes Enzymes for β-lactam Antibiotics Product Portfolio Table 90. Creative Enzymes Recent Development Table 91. Fermenta Biotech Ltd. Company Information Table 92. Fermenta Biotech Ltd. Business Overview Table 93. Fermenta Biotech Ltd. Enzymes for β-lactam Antibiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Fermenta Biotech Ltd. Enzymes for β-lactam Antibiotics Product Portfolio Table 95. Fermenta Biotech Ltd. Recent Development Table 96. Merck & Co. Company Information Table 97. Merck & Co. Business Overview Table 98. Merck & Co. Enzymes for β-lactam Antibiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Merck & Co. Enzymes for β-lactam Antibiotics Product Portfolio Table 100. Merck & Co. Recent Development Table 101. MuseChem Chemicals Company Information Table 102. MuseChem Chemicals Business Overview Table 103. MuseChem Chemicals Enzymes for β-lactam Antibiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. MuseChem Chemicals Enzymes for β-lactam Antibiotics Product Portfolio Table 105. MuseChem Chemicals Recent Development Table 106. Biolab Company Information Table 107. Biolab Business Overview Table 108. Biolab Enzymes for β-lactam Antibiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Biolab Enzymes for β-lactam Antibiotics Product Portfolio Table 110. Biolab Recent Development Table 111. Hangzhou Chuangke Biotech Company Information Table 112. Hangzhou Chuangke Biotech Business Overview Table 113. Hangzhou Chuangke Biotech Enzymes for β-lactam Antibiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Hangzhou Chuangke Biotech Enzymes for β-lactam Antibiotics Product Portfolio Table 115. Hangzhou Chuangke Biotech Recent Development Table 116. Hangzhou Junfeng Bioengineering Company Information Table 117. Hangzhou Junfeng Bioengineering Business Overview Table 118. Hangzhou Junfeng Bioengineering Enzymes for β-lactam Antibiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Hangzhou Junfeng Bioengineering Enzymes for β-lactam Antibiotics Product Portfolio Table 120. Hangzhou Junfeng Bioengineering Recent Development Table 121. Hunan Fulaige Biotech Company Information Table 122. Hunan Fulaige Biotech Business Overview Table 123. Hunan Fulaige Biotech Enzymes for β-lactam Antibiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Hunan Fulaige Biotech Enzymes for β-lactam Antibiotics Product Portfolio Table 125. Hunan Fulaige Biotech Recent Development Table 126. Shanghai Kekai Biotech Company Information Table 127. Shanghai Kekai Biotech Business Overview Table 128. Shanghai Kekai Biotech Enzymes for β-lactam Antibiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Shanghai Kekai Biotech Enzymes for β-lactam Antibiotics Product Portfolio Table 130. Shanghai Kekai Biotech Recent Development Table 131. Key Raw Materials Table 132. Raw Materials Key Suppliers Table 133. Enzymes for β-lactam Antibiotics Distributors List Table 134. Enzymes for β-lactam Antibiotics Customers List Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Enzymes for β-lactam Antibiotics Product Image Figure 2. Global Enzymes for β-lactam Antibiotics Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Enzymes for β-lactam Antibiotics Sales Value (2021-2032) & (US$ Million) Figure 4. Global Enzymes for β-lactam Antibiotics Sales (2021-2032) & (K Units) Figure 5. Global Enzymes for β-lactam Antibiotics Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Enzymes for β-lactam Antibiotics Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Penicillin Acylase Image Figure 10. β-lactamase Image Figure 11. Other Image Figure 12. Global Enzymes for β-lactam Antibiotics Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Enzymes for β-lactam Antibiotics Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Enzymes for β-lactam Antibiotics Sales Volume Share by Type (2021-2032) Figure 15. Global Enzymes for β-lactam Antibiotics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Enzymes for β-lactam Antibiotics Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Enzymes for β-lactam Antibiotics Sales Value Share by Type (2021-2032) Figure 18. Cephalosporins Image Figure 19. Penicillin and Its Derivatives Image Figure 20. Monoamide Ring Image Figure 21. Other Image Figure 22. Global Enzymes for β-lactam Antibiotics Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Enzymes for β-lactam Antibiotics Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Enzymes for β-lactam Antibiotics Sales Volume Share by Application (2021-2032) Figure 25. Global Enzymes for β-lactam Antibiotics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Enzymes for β-lactam Antibiotics Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Enzymes for β-lactam Antibiotics Sales Value Share by Application (2021-2032) Figure 28. Global Enzymes for β-lactam Antibiotics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Enzymes for β-lactam Antibiotics Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Enzymes for β-lactam Antibiotics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Enzymes for β-lactam Antibiotics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Enzymes for β-lactam Antibiotics Sales Value (2021-2032) & (US$ Million) Figure 33. North America Enzymes for β-lactam Antibiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Enzymes for β-lactam Antibiotics Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Enzymes for β-lactam Antibiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Enzymes for β-lactam Antibiotics Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Enzymes for β-lactam Antibiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Enzymes for β-lactam Antibiotics Sales Value (2021-2032) & (US$ Million) Figure 39. South America Enzymes for β-lactam Antibiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Enzymes for β-lactam Antibiotics Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Enzymes for β-lactam Antibiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Enzymes for β-lactam Antibiotics Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Enzymes for β-lactam Antibiotics Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Penicillin Acylase
  • β-lactamase
  • Other
Applications
  • Cephalosporins
  • Penicillin and Its Derivatives
  • Monoamide Ring
  • Other
Companies covered
  • MCE
  • Amicogen
  • Biosynth
  • Crawford Wisdom International
  • Creative Enzymes
  • Fermenta Biotech Ltd.
  • Merck & Co.
  • MuseChem Chemicals
  • Biolab
  • Hangzhou Chuangke Biotech
  • Hangzhou Junfeng Bioengineering
  • Hunan Fulaige Biotech
  • Shanghai Kekai Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Enzymes for β-lactam Antibiotics Sales Value (2021-2032)
  4. 1.2.2 Global Enzymes for β-lactam Antibiotics Sales Volume (2021-2032)
  5. 1.2.3 Global Enzymes for β-lactam Antibiotics Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Enzymes for β-lactam Antibiotics Market Dynamics
  1. 2.1 Enzymes for β-lactam Antibiotics Industry Trends
  2. 2.2 Enzymes for β-lactam Antibiotics Industry Drivers
  3. 2.3 Enzymes for β-lactam Antibiotics Industry Opportunities and Challenges
  4. 2.4 Enzymes for β-lactam Antibiotics Industry Restraints
3 Enzymes for β-lactam Antibiotics Market by Company
  1. 3.1 Global Enzymes for β-lactam Antibiotics Company Revenue Ranking in 2025
  2. 3.2 Global Enzymes for β-lactam Antibiotics Revenue by Company (2021-2026)
  3. 3.3 Global Enzymes for β-lactam Antibiotics Sales Volume by Company (2021-2026)
  4. 3.4 Global Enzymes for β-lactam Antibiotics Average Price by Company (2021-2026)
  5. 3.5 Global Enzymes for β-lactam Antibiotics Company Ranking (2024-2026)
  6. 3.6 Global Enzymes for β-lactam Antibiotics Company Manufacturing Base and Headquarters
  7. 3.7 Global Enzymes for β-lactam Antibiotics Company Product Type and Application
  8. 3.8 Global Enzymes for β-lactam Antibiotics Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Enzymes for β-lactam Antibiotics Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Enzymes for β-lactam Antibiotics Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Enzymes for β-lactam Antibiotics Market by Type
  1. 4.1 Enzymes for β-lactam Antibiotics Type Introduction
  2. 4.1.1 Penicillin Acylase
  3. 4.1.2 β-lactamase
  4. 4.1.3 Other
  5. 4.2 Global Enzymes for β-lactam Antibiotics Sales Volume by Type
  6. 4.2.1 Global Enzymes for β-lactam Antibiotics Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Enzymes for β-lactam Antibiotics Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Enzymes for β-lactam Antibiotics Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Enzymes for β-lactam Antibiotics Sales Value by Type
  10. 4.3.1 Global Enzymes for β-lactam Antibiotics Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Enzymes for β-lactam Antibiotics Sales Value by Type (2021-2032)
  12. 4.3.3 Global Enzymes for β-lactam Antibiotics Sales Value Share by Type (2021-2032)
5 Enzymes for β-lactam Antibiotics Market by Application
  1. 5.1 Enzymes for β-lactam Antibiotics Application Introduction
  2. 5.1.1 Cephalosporins
  3. 5.1.2 Penicillin and Its Derivatives
  4. 5.1.3 Monoamide Ring
  5. 5.1.4 Other
  6. 5.2 Global Enzymes for β-lactam Antibiotics Sales Volume by Application
  7. 5.2.1 Global Enzymes for β-lactam Antibiotics Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Enzymes for β-lactam Antibiotics Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Enzymes for β-lactam Antibiotics Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Enzymes for β-lactam Antibiotics Sales Value by Application
  11. 5.3.1 Global Enzymes for β-lactam Antibiotics Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Enzymes for β-lactam Antibiotics Sales Value by Application (2021-2032)
  13. 5.3.3 Global Enzymes for β-lactam Antibiotics Sales Value Share by Application (2021-2032)
6 Enzymes for β-lactam Antibiotics Regional Sales and Value Analysis
  1. 6.1 Global Enzymes for β-lactam Antibiotics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Enzymes for β-lactam Antibiotics Sales by Region (2021-2032)
  3. 6.2.1 Global Enzymes for β-lactam Antibiotics Sales by Region: 2021-2026
  4. 6.2.2 Global Enzymes for β-lactam Antibiotics Sales by Region (2027-2032)
  5. 6.3 Global Enzymes for β-lactam Antibiotics Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Enzymes for β-lactam Antibiotics Sales Value by Region (2021-2032)
  7. 6.4.1 Global Enzymes for β-lactam Antibiotics Sales Value by Region: 2021-2026
  8. 6.4.2 Global Enzymes for β-lactam Antibiotics Sales Value by Region (2027-2032)
  9. 6.5 Global Enzymes for β-lactam Antibiotics Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Enzymes for β-lactam Antibiotics Sales Value (2021-2032)
  12. 6.6.2 North America Enzymes for β-lactam Antibiotics Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Enzymes for β-lactam Antibiotics Sales Value (2021-2032)
  15. 6.7.2 Europe Enzymes for β-lactam Antibiotics Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Enzymes for β-lactam Antibiotics Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Enzymes for β-lactam Antibiotics Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Enzymes for β-lactam Antibiotics Sales Value (2021-2032)
  21. 6.9.2 South America Enzymes for β-lactam Antibiotics Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Enzymes for β-lactam Antibiotics Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Enzymes for β-lactam Antibiotics Sales Value Share by Country, 2025 VS 2032
7 Enzymes for β-lactam Antibiotics Country-level Sales and Value Analysis
  1. 7.1 Global Enzymes for β-lactam Antibiotics Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Enzymes for β-lactam Antibiotics Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Enzymes for β-lactam Antibiotics Sales by Country (2021-2032)
  4. 7.3.1 Global Enzymes for β-lactam Antibiotics Sales by Country (2021-2026)
  5. 7.3.2 Global Enzymes for β-lactam Antibiotics Sales by Country (2027-2032)
  6. 7.4 Global Enzymes for β-lactam Antibiotics Sales Value by Country (2021-2032)
  7. 7.4.1 Global Enzymes for β-lactam Antibiotics Sales Value by Country (2021-2026)
  8. 7.4.2 Global Enzymes for β-lactam Antibiotics Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Enzymes for β-lactam Antibiotics Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Enzymes for β-lactam Antibiotics Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Enzymes for β-lactam Antibiotics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 MCE
  2. 8.1.1 MCE Company Information
  3. 8.1.2 MCE Business Overview
  4. 8.1.3 MCE Enzymes for β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 MCE Enzymes for β-lactam Antibiotics Product Portfolio
  6. 8.1.5 MCE Recent Developments
  7. 8.2 Amicogen
  8. 8.2.1 Amicogen Company Information
  9. 8.2.2 Amicogen Business Overview
  10. 8.2.3 Amicogen Enzymes for β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Amicogen Enzymes for β-lactam Antibiotics Product Portfolio
  12. 8.2.5 Amicogen Recent Developments
  13. 8.3 Biosynth
  14. 8.3.1 Biosynth Company Information
  15. 8.3.2 Biosynth Business Overview
  16. 8.3.3 Biosynth Enzymes for β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Biosynth Enzymes for β-lactam Antibiotics Product Portfolio
  18. 8.3.5 Biosynth Recent Developments
  19. 8.4 Crawford Wisdom International
  20. 8.4.1 Crawford Wisdom International Company Information
  21. 8.4.2 Crawford Wisdom International Business Overview
  22. 8.4.3 Crawford Wisdom International Enzymes for β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Crawford Wisdom International Enzymes for β-lactam Antibiotics Product Portfolio
  24. 8.4.5 Crawford Wisdom International Recent Developments
  25. 8.5 Creative Enzymes
  26. 8.5.1 Creative Enzymes Company Information
  27. 8.5.2 Creative Enzymes Business Overview
  28. 8.5.3 Creative Enzymes Enzymes for β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Creative Enzymes Enzymes for β-lactam Antibiotics Product Portfolio
  30. 8.5.5 Creative Enzymes Recent Developments
  31. 8.6 Fermenta Biotech Ltd.
  32. 8.6.1 Fermenta Biotech Ltd. Company Information
  33. 8.6.2 Fermenta Biotech Ltd. Business Overview
  34. 8.6.3 Fermenta Biotech Ltd. Enzymes for β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Fermenta Biotech Ltd. Enzymes for β-lactam Antibiotics Product Portfolio
  36. 8.6.5 Fermenta Biotech Ltd. Recent Developments
  37. 8.7 Merck & Co.
  38. 8.7.1 Merck & Co. Company Information
  39. 8.7.2 Merck & Co. Business Overview
  40. 8.7.3 Merck & Co. Enzymes for β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Merck & Co. Enzymes for β-lactam Antibiotics Product Portfolio
  42. 8.7.5 Merck & Co. Recent Developments
  43. 8.8 MuseChem Chemicals
  44. 8.8.1 MuseChem Chemicals Company Information
  45. 8.8.2 MuseChem Chemicals Business Overview
  46. 8.8.3 MuseChem Chemicals Enzymes for β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 MuseChem Chemicals Enzymes for β-lactam Antibiotics Product Portfolio
  48. 8.8.5 MuseChem Chemicals Recent Developments
  49. 8.9 Biolab
  50. 8.9.1 Biolab Company Information
  51. 8.9.2 Biolab Business Overview
  52. 8.9.3 Biolab Enzymes for β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Biolab Enzymes for β-lactam Antibiotics Product Portfolio
  54. 8.9.5 Biolab Recent Developments
  55. 8.10 Hangzhou Chuangke Biotech
  56. 8.10.1 Hangzhou Chuangke Biotech Company Information
  57. 8.10.2 Hangzhou Chuangke Biotech Business Overview
  58. 8.10.3 Hangzhou Chuangke Biotech Enzymes for β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Hangzhou Chuangke Biotech Enzymes for β-lactam Antibiotics Product Portfolio
  60. 8.10.5 Hangzhou Chuangke Biotech Recent Developments
  61. 8.11 Hangzhou Junfeng Bioengineering
  62. 8.11.1 Hangzhou Junfeng Bioengineering Company Information
  63. 8.11.2 Hangzhou Junfeng Bioengineering Business Overview
  64. 8.11.3 Hangzhou Junfeng Bioengineering Enzymes for β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Hangzhou Junfeng Bioengineering Enzymes for β-lactam Antibiotics Product Portfolio
  66. 8.11.5 Hangzhou Junfeng Bioengineering Recent Developments
  67. 8.12 Hunan Fulaige Biotech
  68. 8.12.1 Hunan Fulaige Biotech Company Information
  69. 8.12.2 Hunan Fulaige Biotech Business Overview
  70. 8.12.3 Hunan Fulaige Biotech Enzymes for β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Hunan Fulaige Biotech Enzymes for β-lactam Antibiotics Product Portfolio
  72. 8.12.5 Hunan Fulaige Biotech Recent Developments
  73. 8.13 Shanghai Kekai Biotech
  74. 8.13.1 Shanghai Kekai Biotech Company Information
  75. 8.13.2 Shanghai Kekai Biotech Business Overview
  76. 8.13.3 Shanghai Kekai Biotech Enzymes for β-lactam Antibiotics Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Shanghai Kekai Biotech Enzymes for β-lactam Antibiotics Product Portfolio
  78. 8.13.5 Shanghai Kekai Biotech Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Enzymes for β-lactam Antibiotics Value Chain Analysis
  2. 9.1.1 Enzymes for β-lactam Antibiotics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Enzymes for β-lactam Antibiotics Sales Mode & Process
  6. 9.2 Enzymes for β-lactam Antibiotics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Enzymes for β-lactam Antibiotics Distributors
  9. 9.2.3 Enzymes for β-lactam Antibiotics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst